RESUMO
Las glomerulonefritis membranoproliferativas son ne-fropatías glomerulares poco frecuentes cuya prevalencia ha disminuido en nuestro medio. Presentan una histología característica y pueden asociarse a diferentes enfermeda-des. La presentación clínica es variada y su diagnóstico de-finitivo requiere realizar una biopsia renal. El tratamiento viene condicionado por la enfermedad de base, tratándose con inmunosupresores cuando existe una disminución del filtrado glomerular.Presentamos el caso de una mujer de 47 años con glo-merulonefritis membranoproliferativa secundaria a infec-ción por de virus de hepatitis C para describir el manejo de este tipo de pacientes, dado que se trata de una patología con una baja prevalencia (AU)
Membranoproliferative glomerulonephritis is an un-common condition that affects the glomeruli of the kid-neys; its prevalence has decreased in our environment. Membranoproliferative glomerulonephritis has a charac-teristic histology that can be associated to different diseas-es. The clinical presentation varies, and to achieve a defin-itive diagnosis a renal biopsy must be done. Treatment is based on the underlying disease; when a drop in glomer-ular filtration rate is detected, immunosuppressants are prescribed.We describe the management of a 47-year-old female with membranoproliferative glomerulonephritis second-ary to hepatitis C virus infection, a condition with very low prevalence (AU)
Assuntos
Humanos , Feminino , Pessoa de Meia-Idade , Glomerulonefrite Membranoproliferativa/terapia , Glomerulonefrite Membranoproliferativa/virologia , Hepatite C/complicaçõesRESUMO
Membranoproliferative glomerulonephritis is an uncommon condition that affects the glomeruli of the kidneys; its prevalence has decreased in our environment. Membranoproliferative glomerulonephritis has a characteristic histology that can be associated to different diseases. The clinical presentation varies, and to achieve a definitive diagnosis a renal biopsy must be done. Treatment is based on the underlying disease; when a drop in glomerular filtration rate is detected, immunosuppressants are prescribed. We describe the management of a 47-year-old female with membranoproliferative glomerulonephritis secondary to hepatitis C virus infection, a condition with very low prevalence.
Assuntos
Glomerulonefrite Membranoproliferativa , Hepatite C , Feminino , Humanos , Pessoa de Meia-Idade , Glomerulonefrite Membranoproliferativa/terapia , Glomerulonefrite Membranoproliferativa/complicações , Hepacivirus , Hepatite C/complicações , Hepatite C/diagnóstico , Hepatite C/tratamento farmacológico , Rim/patologia , NefrectomiaRESUMO
Introducción: La arteritis de Takayasu se trata de una vasculitis de grandes vasos, crónica y granulomatosa caracterizada por la presencia de estenosis y aneurismas en la aorta y sus ramas principales. Se produce inflamación. vascular que causa dolor. Las pruebas de imagen como el PET-TC han ganado importancia en el diagnóstico. El tratamiento se realiza con inmunosupresores, pudiendo usar fármacos biológicos en casos refractarios. Material y métodos: Estudio descriptivo retrospectivo de 3 casos de enfermedad de Takayasu. Resultados: Presentamos 3 casos atípicos de vasculitis de Takayasu que fueron diagnosticados mediante PET-TC y que evolucionaron de forma diferente, requiriendo 2 de ellos tratamiento con fármacos biológicos. Conclusión: Pruebas de imagen como el PET-TC permiten un diagnóstico temprano y un seguimiento de la enfermedad. Con el uso de fármacos biológicos podemos controlar los casos refractarios. (AU)
Introduction: Takayasu's arteritis is a chronic granulomatous vasculitis of large vessels characterized by the presence of stenosis and aneurysms in the aorta and its mainbranches. Vascular inflammation occurs that causes pain. Imaging tests such as PET-CT have gained importance in diagnosis. The treatment is carried out with immunosuppressants, being able to use biological drugs in refractory cases. Material and methods: Retrospective descriptive study of 3 cases of Takayasu's disease. Results: We present 3 atypical cases of Takayasu vasculitis that were diagnosed by PET-CT and that evolved differently, requiring 2 of them treatment with biological drugs. Conclusion: Imaging tests such as PET-CT allow early diagnosis and monitoring of the disease. With the use of biological drugs we can control refractory cases. (AU)
